BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34928621)

  • 1. Is Current Practice Adhering to Guidelines Proposed for Metabolite Identification in LC-MS Untargeted Metabolomics? A Meta-Analysis of the Literature.
    Kodra D; Pousinis P; Vorkas PA; Kademoglou K; Liapikos T; Pechlivanis A; Virgiliou C; Wilson ID; Gika H; Theodoridis G
    J Proteome Res; 2022 Mar; 21(3):590-598. PubMed ID: 34928621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics.
    Chaleckis R; Meister I; Zhang P; Wheelock CE
    Curr Opin Biotechnol; 2019 Feb; 55():44-50. PubMed ID: 30138778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced MS/MS coverage for metabolite identification in LC-MS-based untargeted metabolomics by target-directed data dependent acquisition with time-staggered precursor ion list.
    Wang Y; Feng R; Wang R; Yang F; Li P; Wan JB
    Anal Chim Acta; 2017 Nov; 992():67-75. PubMed ID: 29054151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG; Theodoridis GA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples.
    Broeckling CD; Beger RD; Cheng LL; Cumeras R; Cuthbertson DJ; Dasari S; Davis WC; Dunn WB; Evans AM; Fernández-Ochoa A; Gika H; Goodacre R; Goodman KD; Gouveia GJ; Hsu PC; Kirwan JA; Kodra D; Kuligowski J; Lan RS; Monge ME; Moussa LW; Nair SG; Reisdorph N; Sherrod SD; Ulmer Holland C; Vuckovic D; Yu LR; Zhang B; Theodoridis G; Mosley JD
    Anal Chem; 2023 Dec; 95(51):18645-18654. PubMed ID: 38055671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of GC-MS and LC-MS for untargeted metabolomics profiling.
    Zeki ÖC; Eylem CC; Reçber T; Kır S; Nemutlu E
    J Pharm Biomed Anal; 2020 Oct; 190():113509. PubMed ID: 32814263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MS
    Folberth J; Begemann K; Jöhren O; Schwaninger M; Othman A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1145():122105. PubMed ID: 32305706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
    Cui L; Lu H; Lee YH
    Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry based untargeted metabolomics for plant systems biology.
    Alvarez S; Naldrett MJ
    Emerg Top Life Sci; 2021 May; 5(2):189-201. PubMed ID: 33704399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
    Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
    Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking.
    Zhou Z; Luo M; Zhang H; Yin Y; Cai Y; Zhu ZJ
    Nat Commun; 2022 Nov; 13(1):6656. PubMed ID: 36333358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
    Boonchaisri S; Rochfort S; Stevenson T; Dias DA
    Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge integration strategies for untargeted metabolomics based on MCR-ALS analysis of CE-MS and LC-MS data.
    Ortiz-Villanueva E; Benavente F; Piña B; Sanz-Nebot V; Tauler R; Jaumot J
    Anal Chim Acta; 2017 Jul; 978():10-23. PubMed ID: 28595722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering Regulated Metabolite Families in Untargeted Metabolomics Studies.
    Treutler H; Tsugawa H; Porzel A; Gorzolka K; Tissier A; Neumann S; Balcke GU
    Anal Chem; 2016 Aug; 88(16):8082-90. PubMed ID: 27452369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public LC-Orbitrap Tandem Mass Spectral Library for Metabolite Identification.
    Phapale P; Palmer A; Gathungu RM; Kale D; Brügger B; Alexandrov T
    J Proteome Res; 2021 Apr; 20(4):2089-2097. PubMed ID: 33529026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced detection and identification in metabolomics by use of LC-MS/MS untargeted analysis in combination with gas-phase fractionation.
    Calderón-Santiago M; Priego-Capote F; Luque de Castro MD
    Anal Chem; 2014 Aug; 86(15):7558-65. PubMed ID: 24992377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A perspective on the standards describing mass spectrometry-based metabolic phenotyping (metabolomics/metabonomics) studies in publications.
    Wilson ID; Theodoridis G; Virgiliou C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122515. PubMed ID: 33460910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen-Deuterium Scrambling Based on Chemical Isotope Labeling Coupled with LC-MS: Application to Amine Metabolite Identification in Untargeted Metabolomics.
    Zheng SJ; Zheng J; Xiong CF; Xiao HM; Liu SJ; Feng YQ
    Anal Chem; 2020 Jan; 92(2):2043-2051. PubMed ID: 31894964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated strategy to improve data acquisition and metabolite identification by time-staggered ion lists in UHPLC/Q-TOF MS-based metabolomics.
    Wang Y; Feng R; He C; Su H; Ma H; Wan JB
    J Pharm Biomed Anal; 2018 Aug; 157():171-179. PubMed ID: 29802989
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.